Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia. [electronic resource] by
- Buscarini, Elisabetta
- Botella, Luisa Maria
- Geisthoff, Urban
- Kjeldsen, Anette D
- Mager, Hans Jurgen
- Pagella, Fabio
- Suppressa, Patrizia
- Zarrabeitia, Roberto
- Dupuis-Girod, Sophie
- Shovlin, Claire L
Producer: 20190419
In:
Orphanet journal of rare diseases vol. 14
Availability: No items available.
|
|
13.
|
|
|
14.
|
MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells. [electronic resource] by
- Tabruyn, Sebastien P
- Hansen, Sylvain
- Ojeda-Fernández, Maria-Luisa
- Bovy, Nicolas
- Zarrabeitia, Roberto
- Recio-Poveda, Lucia
- Bernabéu, Carmelo
- Martial, Joseph A
- Botella, Luisa-Maria
- Struman, Ingrid
Producer: 20140430
In:
Angiogenesis vol. 16
Availability: No items available.
|
|
15.
|
|
|
16.
|
11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells. [electronic resource] by
- Aguado, Tania
- Romero-Revilla, José A
- Granados, Rosario
- Campuzano, Susana
- Torrente-Rodríguez, Rebeca M
- Cuesta, Ángel M
- Albiñana, Virginia
- Botella, Luisa María
- Santamaría, Silvia
- Garcia-Sanz, Jose A
- Pingarrón, José Manuel
- Sánchez-Sancho, Francisco
- Sánchez-Puelles, José-María
Producer: 20201021
In:
Scientific reports vol. 9
Availability: No items available.
|